Armata Pharmaceuticals (ARMP) Short term Debt (2018 - 2025)
Armata Pharmaceuticals' (ARMP) quarterly Short term Debt came in at $48.1 million in Q3 2025, up 16.28% year-on-year from $41.4 million in Q3 2024, and up 43.78% quarter-over-quarter from $33.4 million in Q2 2025.
Armata Pharmaceuticals (ARMP) Short term Debt (2018 - 2025) Analysis & Trends
Armata Pharmaceuticals has disclosed Short term Debt across 5 years of filings, most recently posting $48.1 million for Q3 2025.
- Short term Debt for Q3 2025 came in at $48.1 million, up 16.28% year-over-year; the trailing twelve-month figure through Sep 2025 was $48.1 million (up 16.28% YoY), and the FY2020 annual result was $1.9 million, up 100.0% from the prior year.
- Short term Debt came in at $48.1 million for Q3 2025 at Armata Pharmaceuticals, up from $33.4 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $71.7 million in Q1 2024 to a low of $27.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Armata Pharmaceuticals | 275.44 Mn | 270.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 48.09 Mn |
| Jun 30, 2025 | 33.45 Mn |
| Mar 31, 2025 | 27.69 Mn |
| Sep 30, 2024 | 41.36 Mn |
| Jun 30, 2024 | 48.26 Mn |
| Mar 31, 2024 | 71.66 Mn |
| Dec 31, 2020 | 1.94 Mn |
| Sep 30, 2020 | 1.77 Mn |
| Jun 30, 2020 | 1.62 Mn |
| Mar 31, 2020 | 1.48 Mn |
| Dec 31, 2019 | 970,000.00 |
| Sep 30, 2019 | 885,000.00 |
| Jun 30, 2019 | 769,000.00 |
| Dec 31, 2018 | 970,000.00 |